We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
+$710M
Cap. Flow
+$33.6M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$31M
2
BTI icon
British American Tobacco
BTI
+$29.2M
3
SAP icon
SAP
SAP
+$27.1M
4
HOOD icon
Robinhood
HOOD
+$17.9M
5
CLS icon
Celestica
CLS
+$13.7M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.1M
2
TSM icon
TSMC
TSM
+$26.3M
3
META icon
Meta Platforms (Facebook)
META
+$23.5M
4
BEKE icon
KE Holdings
BEKE
+$22.1M
5
TCOM icon
Trip.com Group
TCOM
+$17M

Sector Composition

Rank Sector Weight
1 Technology 46.19%
2 Consumer Discretionary 14.25%
3 Communication Services 13.85%
4 Healthcare 7.17%
5 Consumer Staples 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
476
Wave Life Sciences
WVE
$1.11B
$25.4K ﹤0.01%
3,905
– –
ELVN icon
477
Enliven Therapeutics
ELVN
$3.85B
$25.1K ﹤0.01%
1,251
– –
JBGS
478
JBG SMITH
JBGS
$820M
$25.1K ﹤0.01%
1,450
-70
-5% -$1.14K
DYN icon
479
Dyne Therapeutics
DYN
$4.8B
$24.8K ﹤0.01%
2,605
– –
ELME
480
Elme Communities
ELME
$144M
$24.7K ﹤0.01%
1,553
-114
-7% -$1.81K
NTLA icon
481
Intellia Therapeutics
NTLA
$1.55B
$24.5K ﹤0.01%
2,608
– –
COLL icon
482
Collegium Pharmaceutical
COLL
$1.17B
$24.4K ﹤0.01%
826
– –
NTST
483
NETSTREIT Corp
NTST
$2.1B
$24.4K ﹤0.01%
1,441
-104
-7% -$1.67K
VERV
484
DELISTED
Verve Therapeutics
VERV
$24.3K ﹤0.01%
2,167
– –
ARDX icon
485
Ardelyx
ARDX
$1.25B
$23.8K ﹤0.01%
6,064
– –
SILA
486
DELISTED
Sila Realty Trust
SILA
$23.5K ﹤0.01%
994
-48
-5% -$1.21K
XHR
487
Xenia Hotels & Resorts
XHR
$1.85B
$22.9K ﹤0.01%
1,825
-88
-5% -$1.01K
ALEX
488
DELISTED
Alexander & Baldwin
ALEX
$22.9K ﹤0.01%
1,283
-93
-7% -$1.62K
UMH
489
UMH Properties
UMH
$1.3B
$22.8K ﹤0.01%
1,355
-65
-5% -$1.11K
SYRE icon
490
Spyre Therapeutics
SYRE
$8.81B
$22.5K ﹤0.01%
1,502
– –
GMAB icon
491
Genmab
GMAB
$17.6B
$22.2K ﹤0.01%
1,073
– –
ZYME icon
492
Zymeworks
ZYME
$1.67B
$22.1K ﹤0.01%
1,763
– –
VRE
493
DELISTED
Veris Residential
VRE
$22K ﹤0.01%
1,476
-108
-7% -$1.66K
AVDL
494
DELISTED
Avadel Pharmaceuticals
AVDL
$21.8K ﹤0.01%
2,467
– –
GERN icon
495
Geron
GERN
$860M
$21.8K ﹤0.01%
15,480
– –
AIV
496
Aimco
AIV
$383M
$21K ﹤0.01%
2,424
-118
-5% -$954
PEB icon
497
Pebblebrook Hotel Trust
PEB
$2.12B
$20.9K ﹤0.01%
2,093
-168
-7% -$1.56K
NRIX icon
498
Nurix Therapeutics
NRIX
$2.45B
$20.7K ﹤0.01%
1,814
– –
LENZ
499
LENZ Therapeutics
LENZ
$181M
$20.6K ﹤0.01%
704
– –
ESRT icon
500
Empire State Realty Trust
ESRT
$862M
$20.6K ﹤0.01%
2,545
-124
-5% -$949
18 19
20
21 22

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q2 2025 Portfolio in Review

As of Q2 2025, GF Fund Management held 701 positions worth $4.97B, up 17% from $4.26B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q2 2025 filing shows 35 new, 130 increased, 246 reduced and 41 closed positions. Its largest new stake was Shopify: 120,000 shares worth $13.8M. The largest sale was NVIDIA, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q2 2025 buy was Shopify: 120,000 shares worth $13.8M.
  • GF Fund Management added most to UnitedHealth in Q2 2025, an estimated $31M increase.
  • GF Fund Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $29.1M.
  • GF Fund Management fully exited Salesforce in Q2 2025, selling an estimated $9.77M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.97B portfolio in Q2 2025.
  • GF Fund Management opened 35 new positions and closed 41 in Q2 2025.
  • GF Fund Management's portfolio value rose 17% quarter-over-quarter to $4.97B.

Based on GF Fund Management's 13F filing for Q2 2025, filed 22 Jul 2025.